Authors:
BULL EK
CHAKRABARTY S
BRODSKY I
HAINES DS
Citation: Ek. Bull et al., MDM2-P2 TRANSCRIPT LEVELS PREDICT THE FUNCTIONAL-ACTIVITY OF THE P53 TUMOR-SUPPRESSOR IN PRIMARY LEUKEMIC-CELLS, Oncogene, 16(17), 1998, pp. 2249-2257
Citation: I. Brodsky, BUSULFAN VERSUS HYDROXYUREA IN THE TREATMENT OF POLYCYTHEMIA-VERA (PV) AND ESSENTIAL THROMBOCYTHEMIA (ET), American journal of clinical oncology, 21(1), 1998, pp. 105-106
Authors:
PAZ HL
GARLAND A
WEINAR M
CRILLEY P
BRODSKY I
Citation: Hl. Paz et al., EFFECT OF CLINICAL OUTCOMES DATA ON INTENSIVE-CARE UNIT UTILIZATION BY BONE-MARROW TRANSPLANT PATIENTS, Critical care medicine, 26(1), 1998, pp. 66-70
Authors:
MICHAELIAN KH
LAPIDES I
LAHAV N
YARIV S
BRODSKY I
Citation: Kh. Michaelian et al., INFRARED STUDY OF THE INTERCALATION OF KAOLINITE BY CESIUM BROMIDE AND CESIUM IODIDE, Journal of colloid and interface science (Print), 204(2), 1998, pp. 389-393
Authors:
ONYEMERE K
LIPTON R
BAUMANN E
SILVERMAN B
BRODSKY I
GHAI K
RICH B
THORP F
Citation: K. Onyemere et al., ONSET FEATURES OF INSULIN-TREATED ATYPICAL TYPE-1 AND EARLY-ONSET TYPE-2 DIABETES IN AFRICAN-AMERICAN AND US LATINO CHILDREN, Diabetes, 47, 1998, pp. 337-337
Authors:
PETRI M
JONES RJ
SMITH BD
BRODSKY I
ANHALT G
BRODSKY RA
Citation: M. Petri et al., HIGH-DOSE CYCLOPHOSPHAMIDE (CY) WITHOUT BONE-MARROW TRANSPLANT (BMT) FOR REFRACTORY SEVERE AUTOIMMUNE-DISEASES (SADS), Arthritis and rheumatism, 41(9), 1998, pp. 1255-1255
Authors:
ROUSSO I
KHATCHATRYAN E
BRODSKY I
NACHUSTAI R
OTTOLENGHI M
SHEVES M
LEWIS A
Citation: I. Rousso et al., ATOMIC-FORCE SENSING OF LIGHT-INDUCED PROTEIN DYNAMICS WITH MICROSECOND TIME RESOLUTION IN BACTERIORHODOPSIN AND PHOTOSYNTHETIC REACTION CENTERS, Journal of structural biology, 119(2), 1997, pp. 158-164
Authors:
SOSLAU G
MORGAN DA
JAFFE JS
BRODSKY I
WANG Y
Citation: G. Soslau et al., CYTOKINE MESSENGER-RNA EXPRESSION IN HUMAN PLATELETS AND A MEGAKARYOCYTIC CELL-LINE AND CYTOKINE MODULATION OF PLATELET-FUNCTION, Cytokine, 9(6), 1997, pp. 405-411
Authors:
MARKS DI
KURZ BW
LINK MP
NG E
SHUSTER JJ
LAUER SJ
CARROLL D
BRODSKY I
HAINES DS
Citation: Di. Marks et al., ALTERED EXPRESSION OF P53 AND MDM-2 PROTEINS AT DIAGNOSIS IS ASSOCIATED WITH EARLY TREATMENT FAILURE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of clinical oncology, 15(3), 1997, pp. 1158-1162
Authors:
GERTSBERG I
BRODSKY I
PRIEL Z
DANILENKO M
Citation: I. Gertsberg et al., NA-K+-ATPASE IN FROG ESOPHAGUS MUCOCILIARY CELL-MEMBRANES - INHIBITION BY PROTEIN-KINASE-C ACTIVATION(), American journal of physiology. Cell physiology, 42(6), 1997, pp. 1842-1848
Citation: Da. Morgan et al., CYTOKINE-MEDIATED ERYTHROID MATURATION IN MEGAKARYOBLASTIC HUMAN CELL-LINE HU-3, Experimental hematology, 25(13), 1997, pp. 1378-1385
Authors:
SOSLAU G
SILVERBERG M
BRODSKY I
MCCARTY PP
Citation: G. Soslau et al., ATP MODIFICATION OF SEROTONIN-INDUCED CONTRACTION OF THE RAT PULMONARY-ARTERY, Proceedings of the Society for Experimental Biology and Medicine, 214(3), 1997, pp. 233-241
Authors:
ROUSSO I
KHACHATRYAN E
GAT Y
BRODSKY I
OTTOLENGHI M
SHEVES M
LEWIS A
Citation: I. Rousso et al., MICROSECOND ATOMIC-FORCE SENSING OF PROTEIN CONFORMATIONAL DYNAMICS -IMPLICATIONS FOR THE PRIMARY LIGHT-INDUCED EVENTS IN BACTERIORHODOPSIN, Proceedings of the National Academy of Sciences of the United Statesof America, 94(15), 1997, pp. 7937-7941
Authors:
CRILLEY P
TOPOLSKY DL
STYLER MJ
BRODSKY I
Citation: P. Crilley et al., SUSTAINED ENGRAFTMENT IN MATCHED UNRELATED DONOR TRANSPLANT (MUD) RECIPIENTS WITH HEMATOLOGIC MALIGNANCIES WITH A BUSULFAN-CYCLOPHOSPHAMIDEMARROW PREPARATIVE REGIMEN, Blood, 90(10), 1997, pp. 4524-4524
Authors:
ILDSTAD ST
CRILLEY PA
SHADDUCK RK
KAUFMAN CL
MIRRO J
BRODSKY I
BRUGGER W
GAJEWSKI JL
PRZEPIORKA D
STYLER MJ
LISTER J
TOPOLSKY DL
MANZ M
KANZ L
CHAMPLIN RL
Citation: St. Ildstad et al., GRAFT ENGINEERING - THE FACILITATING CELL (FC) PROTOCOL IN HLA MISMATCHED BMT FOR HEMATOLOGIC MALIGNANCY, Blood, 90(10), 1997, pp. 484-484
Authors:
BRODSKY RA
SMITH BD
BRODSKY I
ANHALT G
PETRI M
JONES RJ
Citation: Ra. Brodsky et al., HIGH-DOSE CYCLOPHOSPHAMIDE (CY) WITHOUT BONE-MARROW TRANSPLANT (BMT) FOR REFRACTORY SEVERE AUTOIMMUNE-DISEASES (SADS), Blood, 90(10), 1997, pp. 1028-1028
Authors:
SOSLAU G
MORAN DA
CLASS R
BRODSKY I
MARCHESE P
RUGGERI ZM
Citation: G. Soslau et al., AGGREGATION OF HUMAN PLATELETS AND MEGAKARYOCYTE-LIKE CELLS (HU3) INDUCED BY A NON-RGDS FIBRIN, NONPROTEOLYTIC THROMBIN-GPIB PATHWAY, Blood, 90(10), 1997, pp. 1251-1251
Authors:
BRODSKY RA
SMITH BD
CHEN A
DOEBLIN TD
DORR D
BRODSKY I
JONES RJ
Citation: Ra. Brodsky et al., HIGH-DOSE CYCLOPHOSPHAMIDE (CY) WITHOUT BONE-MARROW TRANSPLANT (BMT) FOR NEWLY-DIAGNOSED OR REFRACTORY SEVERE APLASTIC-ANEMIA (SAA), Blood, 90(10), 1997, pp. 1952-1952
Citation: Mt. Boyd et al., EVIDENCE FOR COPURIFICATION OF HERV-K-RELATED TRANSCRIPTS AND A REVERSE-TRANSCRIPTASE ACTIVITY IN HUMAN PLATELETS FROM PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA, Blood, 90(10), 1997, pp. 4022-4030
Authors:
HAINES DS
MARKS DI
KURZ BI
LINK MP
NG E
SHUSTER JJ
LAUER SJ
CARROLL D
BRODSKY I
Citation: Ds. Haines et al., MDM-2 OVEREXPRESSION AND P53 GENE MUTATION AT DIAGNOSIS ARE ASSOCIATED WITH EARLY TREATMENT FAILURE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of clinical oncology, 14(5), 1996, pp. 2018-2018
Authors:
CRILLEY P
TOPOLSKY D
MARKS DI
STYLER M
SABOL P
BRODSKY I
Citation: P. Crilley et al., LOW INCIDENCE OF FUNGAL-INFECTIONS IN PATIENTS UNDERGOING UNRELATED DONOR BONE-MARROW TRANSPLANTS FOLLOWED BY GM-CSF, Experimental hematology, 24(9), 1996, pp. 633-633
Authors:
COPELAN EA
BIGGS JC
SZER J
CRILLEY P
ATKINSON K
AVALOS B
TOPOLSKY D
PENZA SL
ELDER PJ
BULOVA SL
BRODSKY I
Citation: Ea. Copelan et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION AFTER PREPARATION WITH BUCY2, Experimental hematology, 24(9), 1996, pp. 670-670
Authors:
STYLER MJ
CRILLEY P
BIGGS J
MOUL J
COPELAN E
TOPOLSKY D
AVALOS B
PENZA S
SABOL P
DOWNS K
SZER J
BRODSKY I
MARKS DI
Citation: Mj. Styler et al., HEPATIC-DYSFUNCTION FOLLOWING BUSULFAN AND CYCLOPHOSPHAMIDE MYELOABLATION - A RETROSPECTIVE, MULTICENTER ANALYSIS, Bone marrow transplantation, 18(1), 1996, pp. 171-176